Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05092022 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Primary completion date changed from estimate of Jul 31, 2026 to Jul 23, 2026
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
  2. Primary completion date: Jun 30, 2026 to Jul 31, 2026v14
  3. Primary completion date: Jun 30, 2025 to Jun 30, 2026
    • Study completion date: Jun 30, 2025 to Dec 31, 2026
    • Site contact updated
    v13
  4. Primary and study completion dates: Dec 31, 2024 to Jun 30, 2025
    • Site contact updated
    v12
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v11
Show 9 earlier versionsHide 9 earlier versions
  1. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024
    • Start date: Sep 1, 2023 to Sep 18, 2023
    v10
  2. Start date: Jul 15, 2023 to Sep 1, 2023
    • Primary and study completion dates: Aug 31, 2023 to Dec 31, 2023
    v9
  3. Start date: Jun 1, 2023 to Jul 15, 2023v8
  4. Start date: Apr 1, 2023 to Jun 1, 2023v7
  5. Start date: Mar 1, 2023 to Apr 1, 2023
    • Primary and study completion dates: Jul 31, 2023 to Aug 31, 2023
    v6
  6. Start date: Dec 1, 2022 to Mar 1, 2023v5
  7. Primary and study completion dates: Dec 31, 2022 to Jul 31, 2023
    • Start date: Jul 1, 2022 to Dec 1, 2022
    v4
  8. Start date: Apr 1, 2022 to Jul 1, 2022v3
  9. Start date: Jan 1, 2022 to Apr 1, 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the effectiveness of offering self-sampled human papillomavirus (HPV) tests in increasing participation in cervical cancer screening, compared to the standard of care clinician-sampled test. The primary study endpoints are (1) patients' acceptability of self-sampled HPV tests vs. clinician-sampled test, and (2) patients' completion of self-sampled HPV test. The secondary study endpoint to be measured is the increase in cervical cancer screenings of any type in the PSH St. Joseph's residency clinic patient population.
Trial Details
NCT Number NCT05092022
Lead Sponsor Milton S. Hershey Medical Center
Conditions
(from sponsor)		 Cervical Cancer Screening
Related terms Uterine Cervical Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov